Encompass Health (NYSE:EHC) EVP John Patrick Darby Sells 4,858 Shares of Stock

Posted by Francis Steltz on Sep 1st, 2026

Encompass Health Corporation (NYSE:EHC – Get Free Report) EVP John Patrick Darby sold 4,858 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the sale, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

John Patrick Darby also recently made the following trade(s):

On Monday, August 10th, John Patrick Darby sold 8,906 shares of Encompass Health stock. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70.

Encompass Health Stock Up 1.3%

EHC stock traded up $1.55 during mid-day trading on Tuesday, reaching $121.77. 291,553 shares of the company traded hands, compared to its average volume of 1,060,619. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm’s 50 day moving average price is $113.64 and its 200 day moving average price is $107.27. The stock has a market cap of $12.01 billion, a price-to-earnings ratio of 19.83, a P/E/G ratio of 2.45 and a beta of 0.72. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the prior year, the business posted $1.40 earnings per share. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, equities research analysts predict that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s payout ratio is currently 12.38%.

Institutional Trading of Encompass Health

Several hedge funds have recently added to or reduced their stakes in the stock. California State Teachers Retirement System grew its position in shares of Encompass Health by 9,758.8% during the 2nd quarter. California State Teachers Retirement System now owns 11,605,197 shares of the company’s stock valued at $1,173,053,000 after acquiring an additional 11,487,483 shares during the period. BlackRock Inc. purchased a new position in Encompass Health in the second quarter valued at approximately $1,059,762,000. Price T Rowe Associates Inc. MD lifted its stake in Encompass Health by 24.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock valued at $510,047,000 after purchasing an additional 948,202 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares during the period. Finally, Wellington Management Group LLP increased its position in Encompass Health by 21.7% in the fourth quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company’s stock worth $359,271,000 after buying an additional 603,472 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on EHC shares. Truist Financial lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, August 7th. TD Cowen raised their price target on shares of Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Weiss Ratings upgraded shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 12th. Barclays upped their price objective on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and an average price target of $148.71.

Read Our Latest Analysis on Encompass Health

Encompass Health Company Profile

(Get Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.